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Binding kineticsThe N-terminal part of the inhibitory peptide IF1 interacts with the central γ subunit of mitochondrial isolated
extrinsic part of ATP synthase in the inhibited complex (J.R. Gledhill, M.G. Montgomery, G.W. Leslie, J.E. Walker,
2007). To explore its role in the different steps of IF1 binding, kinetics of inhibition of the isolated andmembrane-
bound enzymes were investigated using Saccharomyces cerevisiae IF1 derivatives modiﬁed in N-terminal
extremity. First,we studiedpeptides truncated inNterup to the amino acid immediately preceding Phe17, awell-
conserved residue thought to play a key role. These deletions did not affect or even improve the access of IF1 to its
target. They decreased the stability of the inhibited complex but much less than previously proposed. We also
mutated IF1-Phe17 and found this amino acid not mandatory for the inhibitory effect. The most striking ﬁnding
came from experiments in which PsaE, a 8 kDa globular-like protein, was attached in Nter of IF1. Unexpectedly,
such a modiﬁcation did not appreciably affect the rate of IF1 binding. Taken together, these data show that
IF1-Nter plays no role in the recognition step but contributes to stabilize the inhibited complex. Moreover, the
data obtainedusing chimeric PsaE-IF1 suggest that before binding IF1 presents to the enzymewith itsmiddle part
facing a catalytic interface and its Nter extremity folded in the opposite direction.C 3.6.3.14); F1-ATPase, isolated
y peptide of mitochondrial ATP
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ATP synthases (also called F0F1-ATPases) are anchored to bacterial
cytoplasmic membranes, mitochondrial inner membranes, and chloro-
plast thylakoid membranes. These enzymatic complexes comprise an
extrinsic F1 domain (α3β3γδε in mitochondria) and a membranous F0
domain connectedbya central axis and aperipheral stalk. ATP synthases
are rotary motors driven by the redox-generated protonmotive force
(pmf) and they catalyze the condensation of ADP and inorganic
phosphate into ATP [1]. Brieﬂy, the pmf rotates amembranous oligomer
of c subunits, the movement of which is transmitted to the central axis
(γδε) that penetrates the catalytic domain (αβ)3. This asymmetrical
axis sequentially distorts the catalytic sites located at three αβinterfaces, driving ATP synthesis. Its rotation has been directly observed
in single molecule experiments [2], revealing the relationship between
angular motion and catalytic steps [3,4].
Most ATP synthases preferentially work in the direction of ATP
synthesis because they rapidly deactivate when the pmf collapses. In
mitochondria, this process, which ensures speciﬁc inhibition of ATP
hydrolysis but not of ATP synthesis, involves a soluble inhibitory peptide
called IF1 [5]. IF1 binds to the catalytic domainofATP synthase as soonas
the latter starts to hydrolyze ATP, and it is released when the pmf is
restored [6–14]. The reason for this differential binding/release is not yet
understood; its elucidation requires to analyze the dynamics of IF1
binding. Previous studies have distinguished a ﬁrst step, during which
IF1 loosely binds to a catalytic site in an adequate conformation, and a
second step, turnover-dependent, during which it is trapped within the
complex [15,16].
IF1 is present in animals [5], yeasts [17,18], and plants [19,20]. It is a
soluble peptide, 84 residues-long in Bos taurus and 63 residues-long in
Saccharomyces cerevisiae. Its structure is essentially α-helical [21].
Pioneering investigations have shown that bovine IF1 (bIF1) lacking the
ﬁrst 16 residues after partial enzymatic digestion retains the capacity to
inhibit ATPase activity [22]. It has been later reported that the minimal
inhibitory sequence consists of residues 22–46 [23] or 14–47 [24] in
bovine and of residues 17–41 in yeasts [23]. Deletion of the ﬁrst 17
residues in mammal IF1 resulted in a still inhibitory peptide but with a
very low afﬁnity for ATP synthase, whereas conﬂicting results were
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parameters drawn from someof these early experiments [24,25] should
be considered only qualitative because IF1 was pre-incubated with
F1-ATPase or submitochondrial particles (SMP) in a low pH buffer and
ATP hydrolysis assayed after dilution into a high pH buffer. The X-ray
structure of bovine F1-ATPase in a complex with a truncated form of IF1
(residues 1–50) has been published [26]. In this structure, thought to be
that of the dead-end, inhibited complex, IF1 interacts with α, β, and γ
subunits. The C-terminal part of this inhibitory peptide (residues
22–50), which can be deﬁned as the mid-part of the full peptide, is
mainly associated with one of the three catalytic αβ interfaces, named
(αβ)DP in reference to the structure of the non-inhibited complex.
Importantly, the visible part in N-terminus of IF1 (residues 8–21)
appears wrapped around the γ subunit and also interactingwith theαE
subunit. This ﬁnding raises the problemof the role of theNter part of IF1
in the different steps of the inhibitory process. IF1 peptides partially
truncated in Nter have been shown to inhibit ATPase activity after
several minutes of incubation [24,25], but in vivo the inhibitory peptide
very rapidly responds to pmf variations, as shown by the absence of ATP
hydrolysis activity immediately after adding an uncoupler tomitochon-
dria [14]. Therefore, to understand the role of IF1 Nter extremity, it is
necessary to study not only the afﬁnity of IF1 derivatives for their target
but also their kinetics of binding.
The aim of this work was to precise the role of the Nter extremity of
yeast IF1 (yIF1) in the different steps of its binding to ATP synthase—
approach, recognition, and locking. To reach this goal, we produced
increasingly Nter-truncated yIF1 derivatives, up to the Phe17 residue, a
well-conserved residue (Phe22 in bovine) thought to be critical for the
inhibitory effect [27], and we investigated the consequences of these
deletions on the kinetics of inhibition of ATP hydrolysis by yIF1, using
isolated F1-ATPase as well as SMP. Our data also lead to reconsider the
importance for inhibition of the yIF1 Phe17 residue. Finally, whereas
previous studies focused on partial deletions of IF1 Nter extremity, we
also examined the consequences of attaching a small globular-like
peptide to this part of the peptide. The effect of these yIF1modiﬁcations
on its kinetic constant of binding to the enzyme (kon) and on the
apparent dissociation constant of the complex at equilibrium (KI)
suggests an outline of the successive steps of IF1 binding.2. Materials and methods
2.1. Molecular biology
DNA manipulations were carried out following published proce-
dures [28] and the manufacturer recommendations unless otherwise
indicated.
A series of variants of inh1 gene deleted in the region encoding
the yIF1 Nter extremity or mutated at a single position (yIF1 Δ1–13,
Δ1–14, Δ1–15, Δ1–16, Δ1–,17 and F17S) was generated by PCR usingTable 1
Synthetic oligonucleotides used for mutagenesis of sequences encoding Saccharomyces cer
replaced by TGG (Trp) to make protein puriﬁcation easier. It was veriﬁed that this mutation
sequence is considered the wT. This plasmid was used for operations 2–4. The plasmid re
deletions (operations 5–8). For operation 9, the starting pET30a+ plasmid contained inh1 se
F17S-F28W have identical functional properties.
Mutation Oligonucleotides seque
1) Insertion of 9 codons spacer+BamH1 GGTGATCAATTTAACGG
2) Insertion of BamH1 GGTACCGACGACGACGG
3) Addition His6 in Nter PsaE-yIF1 GAAGGAGATATACAGA
4) Deletion Δ1–13 CTGGGTACCGACGACGA
5) Deletion Δ1–14 CGACGACGACGACAAGG
6) Deletion Δ1–15 CGACGACGACGACAAGT
7) Deletion Δ1–16 CGACGACGACGACAAGT
8) Deletion Δ1–17 CGACGACGACGACAAGG
9) Mutation F17S GTCAAGCTCAGAGGATTpairs of primers shown in Table 1. PCR products were isolated after
digestion by DpnI to eliminate matrix DNA. Plasmids were ampliﬁed
in Escherichia coli (DH5RMCR strain) after transformation by electro-
poration using a Bio-Rad (Hercules, CA, USA) Gene Pulser
electroporator.
PsaE gene encoding PsaE protein of Synecchocystis sp. 6803 was
subcloned from pRSET into pET30a+ in 5′ extremity of inh1. PsaE and
inh1 were initially ﬂanked by NdeI restriction site, respectively, in 3′
end and 5′ end. BamH1 restriction site was added in pRSET (5′ end of
PsaE) and pET30a+ (upstream NdeI) by directed mutagenesis. PsaE
was isolated from pRSET by digestion and cloned into pET30a+
plasmid. Resulting plasmids were ampliﬁed in E. coli (DH5RMCR
strain) after transformation by a thermal shock at 42 °C for
45 seconds. The full sequence of plasmids from kanamycin-resistant
clones was checked (Euroﬁns MWG Operon, Ebersberg, Germany).
DNA was puriﬁed using kits provided by Qiagen GmbH (Hilden,
Germany) and by Macherey-Nagel EURL (Hoerdt, France).
2.2. Overexpression and puriﬁcation of wT and mutated yIF1
pET30a+ plasmids containing the wT or modiﬁed inh1 gene were
transformed into BL21(DE3) strain of E.coli by electroporation.
Selected clones were grown at 37 °C in liquid LB medium
supplemented with 30 μg/mL kanamycin. After 2–3 hours, when the
culture absorbance at 600 nm reached 0.6–0.8, yIF1 overexpression
was triggered by adding 0.5 mM isopropyl-β-D-thiogalactopyrano-
side. After 3 hours, cells were harvested incubated for 1 hour at room
temperature with 0.5 mg/mL lysozyme, 1 mM phenylmethylsulfonyl-
ﬂuoride (PMSF), 10 μg/mL RNase, and 10 μg/mL DNase and then
brieﬂy sonicated on ice. The lysate was centrifuged at 25,000×g for
20 min (10 °C). The supernatant was incubated for 1 hour at room
temperature, under gentle stirring, in a column containing Ni-NTA
resin (3 mL, Qiagen GmbH, Hilden, Germany) prepared in buffer A
(0.3 M NaCl and 50 mMNa2HPO4, pH 6.5) supplemented with 10 mM
imidazole.
(i) Constructions of wT, truncated or mutated yIF1 had an
enterokinase cleavage site between the His6 N-terminal exten-
sion and thepeptideof interest. Batcheswerewashedwith buffer
A containing successively 10 and 20mM imidazole. Then 2 mLof
20 mM Tris, 50 mM NaCl (pH 7.4) supplemented with 30 U of
enterokinase was added on the column and the latter was
incubated for 20 hours at room temperature under gentle
shaking to cut the N-terminal extension. Protein of interest was
eluted with 10 mM imidazole buffer A. Fractions containing
proteins were pooled and heated at 90 °C for 10 min and
centrifuged in a Benchtop Centrifuge to eliminate enterokinase.
The supernatant was treated with 10% TCA at 4 °C for 5 min and
centrifuged at 10 °C for 20 min. The pellet was solubilized with
50 mM Na-acetate, pH 5.5 and stored at−20 °C.evisiae IF1. The pET30a+ plasmid contained inh1 sequence with TTC encoding Phe28
does not change the functional properties of the produced protein and therefore this
sulting from operation 4 (deletion Δ1–13) was used as starting plasmid for following
quence with either TTC (Phe) or TGG (Trp) encoding amino acid 28. yIF1 F17S and yIF1
nce (5′ to 3′) Plasmid
TATAGGATGCGGATCCGGAGCCACCGCCGCTAGCAG pRSET
ATCCTCTGAAGGTTCTACCGGGC pET30a+
TGCACCATCACCATCACCACGCCTTAAATCGTGG pET30a+
CGACAAGGAGGATTCGTTTGTTAAAAGGGAAAGG pET30a+
ATTCGTTTGTTAAAAGGG pET30a+
CGTTTGTTAAAAGGG pET30a+
TTGTTAAAAGGGAAAG pET30a+
TTAAAAGGGAAAGGG pET30a+
CGTCTGTTAAAAGGGAAAG pET30a+
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buffer A, His-tagged PsaE-yIF1 proteinwas elutedwith 250 mM
imidazole buffer A. The pooled fractions were dialyzed for
7 hours at room temperature against 50 mM NaCl, 20 Mm Tris,
pH 7.8. Protein was concentrated using Ultrafree®-0.5 Centrif-
ugal Filter Device (cutoff=5000) (Millipore, Bedford, MA,
USA) and stored.
Protein concentration was determined using micro-BCA titration
kit (Pierce Chemical Co., Rockford, IL, USA).
2.3. Characterization of peptides
Puriﬁed peptides were analyzed by SDS–PAGE (12%) and revealed
with Coomassie blue R250.
For immunoblotting, proteins were electrotransferred onto
Hybond-P PVDF membrane (Amersham, Little Chalfont, UK) previ-
ously activated with methanol. The membrane was then saturated for
1 hour at room temperature with 5% milk in Na-phosphate 10 mM,
NaCl 150 mM, 0.5% Tween 20, pH 7.4 (TPBS). Rabbit polyclonal
antibodies speciﬁc to IF1 or mouse polyclonal antibodies speciﬁc to
PsaE in 0.5% milk TPBS were applied overnight at 4 °C. After extensive
washes, goat anti-rabbit antibodies or goat anti-mouse antibodies
coupled to alkaline phosphatase were applied for 1 hour at room
temperature. Phosphatase activity was revealed by colorimetry using
BCIP–NBT.
Theoretical electrical charge of the peptides at pH 6.5 was
calculated from the formula: q=Σ[ni/(1+106. 5−pKi)]−Σ[nj/(1+
10pkj−6. 5)], where i refers to basic residues (Nter, Arg, Lys, His) and j
refers to acidic residues (Asp, Glu, Cys, Tyr, Cter). The calculated
values (number of positive elementary charges per molecule) are
+2.3 (yIF1 wT, yIF1 Δ1–13, yIF1 F17S), +3.3 (yIF1 Δ1–14), +4.3
(yIF1 Δ1–15, yIF1 Δ1–16), and +4.9 (PsaE-yIF1).
2.4. Preparation of submitochondrial particles (SMP) and puriﬁed
F1-ATPase
S. cerevisiae cells (Euroscarf BY4741 MAT a, his3Δ1, leu2Δ0,
met15Δ0, ura3Δ0) were grown at 28 °C in a large volume of strictly
respiratory medium containing 1% yeast extract, 0.1% KH2PO4, 0.12%
SO4(NH4)2, 2% lactate, 60 mg/L leucine, 60 mg/L histidine, 20 mg/L
uracile, 40 mg/Lmethionine, pH 5.5. yIF1-stripped SMP and F1-ATPase
were prepared from cells harvested in exponential phase as
previously described [14,16].
2.5. ATP hydrolysis measurement and kinetic analysis
Continuous monitoring of ATP hydrolysis by F1-ATPase or SMP
coupled to NADH oxidation was carried out spectrophotometrically as
described [14]. The reaction was observed in a stirred and thermo-
stated cuvette (25 °C) containing 50 mM MES pH 6.5, 20 mM KCl,
1 mM MgCl2, 1 mM phosphoenolpyruvate, 20 U/mL pyruvate kinase,
50 U/mL lactate dehydrogenase, 0.4 mM NADH, and 1 mM MgATP. In
the case of SMP, the buffer also contained 1.5 μM antimycin and
1.5 μM FCCP. ATP hydrolysis was initiated by adding F1-ATPase or
SMP and monitored by NADH absorbance decrease at 340 nm. After
2–4 min, yIF1 wT or modiﬁed peptide was injected and ATPase
activity decayed. The spectrophotometric recording was ﬁtted to the
following function corresponding to a monoexponential decay of the
ATPase activity:
y tð Þ = V Ið Þt + V 0ð Þ−V Ið Þð Þ= kapp
h i
1−exp −kappt
 h i
+ y0 ð1Þ
where y(t) is the absorbance at time t, and y0 the absorbance at zero
time deﬁned as the time of IF1 addition. V(0) is the constant rate ofabsorbance variation before IF1 addition in absorbance units per
second (proportional to the initial ATPase activity), V(I) the ﬁnal rate
of absorbance variation after IF1 addition (proportional to the ﬁnal
ATPase activity), and kapp the apparent inhibition rate constant in s−1.
The obtained kapp value was plotted as a function of the inhibitor
concentration [I] to determine the rate constants kon (inM−1 s−1) and
koff (in s−1) according to:
kapp = kon I½  + koff ð2Þ
The relation between the V(I)/V(0) ratio and the inhibitor con-
centration was ﬁtted to the following function:
V Ið Þ= V 0ð Þ = vr + 1−vrð Þ= 1 + I½ = KIð Þ ð3Þ
where vr is the inhibitor-insensitive fraction of V(0) (always lower
than 5%). Theoretically, KI should be equal to the koff/kon ratio. In all of
the experiments, the inhibitor concentration was much higher than
the enzyme concentration. Therefore, the total and free concentra-
tions of inhibitor could be considered identical and constant during
the kinetics of inhibition. This justiﬁes the monoexponential analysis
of the decay (Eq. (1)) and the hyperbolic analysis of the inhibition at
equilibrium (Eq. (3)).
It has been shown [15,16] that the measured rate binding constant
kon of IF1 depends on MgATP concentration because it is actually
modulated by the nucleotide occupancy and the catalytic turnover of
F1-ATPase. Experiments reported here were carried out with 1 mM
MgATP. At this MgATP concentration, the kon value reaches a plateau
and represents the true rate binding constant [15,16].
2.6. Chemicals and reagents
All reagents were of analytical grade. PCR mutagenesis was carried
out using the QuikChange Site-Directed Mutagenesis Kit from
Stratagene (La Jolla, CA, USA). DNA ligase was from New England
Biolabs (Ipswitch, MA, USA). BCIP (5-bromo-4-chloro-3-indolyl
phosphate) and NBT (nitro blue tetrazolium) were from Bethesda
Research Laboratories (Gaithersburg, MD, USA). The yeast extract was
from Difco (Detroit, MI, USA). ATP, NADH, phosphoenolpyruvate,
pyruvate kinase, and lactate dehydrogenase were purchased from
Roche (Basel, Switzerland).
pRSET plasmid containing the PsaE gene, PsaE protein, and anti-
PsaE antibody were kindly provided by Dr Bernard Lagoutte (SB2SM,
CEA Saclay). Anti-IF1 antibodywas a generous gift of Dr Kunio Tagawa
(Osaka, Japan).
3. Results
3.1. Obtaining puriﬁed yIF1-derived peptides
Fig. 1a shows the position of IF1 in the crystallized bovine F1-IF1
complex [26], the structure of which will be the reference throughout
this study. Visible IF1 amino acids close to the F1-ATPase γ subunit
(residues 8–21) are represented in ball-and-sticks. bIF1 Phe22
(analog to yIF1 Phe17), in full atoms, marks the beginning of the
highly conserved IF1 sequence part (Fig. 1c) drawn as α-helix. Fig. 1c
represents the yIF1 truncated forms that were obtained, with 13, 14,
15, and 16 residues removed. The maximal deletion, Δ1–16, stops just
before the conserved Phe17. We have also produced a chimeric
peptide in which PsaE, a component of Photosystem I (here from the
cyanobacterium Synechocystis sp. PCC 6803) was attached to the Nter
extremity of yIF1 via a 9 residues spacer. This peptide (PsaE-yIF1) was
His-tagged in Nter. Cyanobacterial PsaE [29] and bovine F1-ATPase in
complex with bIF1 [26] are represented at the same scale in Fig. 1b.
Fig. 2 shows SDS–PAGE analysis of wT and truncated forms of yIF1 (a)
and of wT yIF1, PsaE, and PsaE-yIF1 (b). No signiﬁcant contaminant
Fig. 1. Position of bovine IF1 in the inhibited complex and sequence of modiﬁed yeast IF1 peptides prepared for this study. Panel a, mitochondrial F1-ATPase in complex with IF1
truncated in the C-terminal (reference 26, pdb entry 2v7q; image edited using Swiss-pdbViewer software). Subunits αDP (left), βDP (middle, forefront), and αE (right) are
represented by transparent shapes. Phe22 (full atoms) is a highly conserved amino acid. The helical region of IF1 from Phe22 to Glu50 is trapped between αDP and βDP. IF1 residues
from Val8 to Ala21 (ball-and-sticks) form a hook-shaped structure around the central axis of F1 formed by the γ subunit. Panel b, image showing the respective sizes of inhibited
F1-ATPase complex and PsaE protein (pdb entry 1gxi). PsaE is represented under two different orientations and its C-terminal residue is highlighted. In PsaE-yIF1 chimera, this
residue was linked to the Nter extremity of yIF1. Panel c, sequence alignment of Bos taurus IF1 (bIF1) and Saccharomyces cerevisiae IF1 (yIF1) and deﬁnition of the different yIF1-
derived peptides prepared for this study. The conserved Phe22 (bovine) or Phe17 (yeast) is boxed. Unless otherwise stated, Phe28 (yeast numbering) was replaced by Trp
(underlined) to facilitate the peptide detection during puriﬁcation. Δ1–13, Δ1–14, Δ1–15, Δ1–16, peptides truncated in Nter. Sequence of PsaE-yIF1 chimera symbolized by a bar;
from left to right, hexahistidine tag in Nter (black), PsaE (hatched), nine residues spacer (gray), and yIF1 (white).
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realized using anti-IF1 and anti-PsaE antibodies are displayed. As
expected, PsaE-IF1 was detected as a single band using each antibody.
3.2. Kinetics of inhibition of ATP hydrolysis by yIF1 truncated forms
All of the experiments were carried out at pH 6.5, which is lower
than matricial pH in vivo. This pH value was chosen to allow better
comparisons with previous reports. Moreover, at higher pH, it may
become very difﬁcult, for some derivatives, to estimate at the same
time the rate and the extent of inhibition. From previous work, at
higher pH, kon is expected to decrease and koff expected to decreaseFig. 2. Analysis of puriﬁed recombinant yeast IF1 and derivatives. Conditions as described un
SDS–PAGE. Panels a and b, Coomassie blue staining. Panel c, immunoblotting using antibodies s
26.6, 17, 14.2, 6.5, and 3.5 kDa, (2)wTyIF1, (3) yIF1Δ1–13, (4) yIF1Δ1–14, (5) yIF1Δ1–15, and (
Panel c, lanes: (1) PsaE, (2) PsaE-yIF1, and (3) wT yIF1.[14]. Other differences with in vivo situation are the very low
concentrations of enzyme and a large excess of yIF1, which remains
however well below its putative matricial concentration. These
conditions are required for kinetic studies. Fig. 3 shows typical
kinetics of F1-ATPase inhibition by wT yIF1 (a) and by its truncated
derivative lacking the ﬁrst 15 residues (b). Both peptides were added
at increasing concentrations. For yIF1 wT (a), the ﬁnal inhibition is
almost completely independent of the inhibitor concentration. This
indicates that the lowest inhibitor concentration used here was much
higher than the KI (or Kd) value. The rate of inhibition increases with
IF1 concentration, which indicates that it is controlled by the rate of
IF1 binding. With the Δ1–15 derivative (b), not only the rate ofder Materials and methods. One microgram of each peptide was loaded and analyzed by
peciﬁc to yIF1 (left) or PsaE (right). Panel a, lanes: (1) marker proteins, molecular weights
6) yIF1Δ1–16. Panel b, lanes: (1)marker proteins, (2)wTyIF1, (3) PsaE-yIF1, and (4) PsaE.
Fig. 3. Time course of ATP hydrolysis and ATPase inhibition monitored by NADH
absorbance at 340 nm. Conditions as described under Materials and methods. Inhibitor
additions indicated by vertical arrows. Panel a, additions of yIF1 wT 30 nM (curve 1),
50 nM (curve 2), 70 nM (curve 3), 100 nM (curve 4) to 1.5 nM F1-ATPase. Panel b,
additions of yIF1 Δ1–15 10 nM (curve 1), 20 nM (curve 2), 50 nM (curve 3), 100 nM
(curve 4) to 0.8 nM F1-ATPase.
Table 2
Binding parameters of yIF1 and derivatives determined on isolated F1-ATPase (without
brackets) and on submitochondrial particles (under brackets). Values calculated from
the data used to build Fig. 4 (isolated F1-ATPase) or from similar data (SMP). Fitting was
performed on non-averaged data to better estimate uncertainties of the parameters.
Indicated uncertainties are those provided by the software (Microcal Origin®). kon was
given by the slope value in the linear Eq. (2) (Materials and methods). The constant KI
(theoretically identical to the equilibrium dissociation constant Kd) was given by the
hyperbolic Eq. (3). koff was given by the KIkon product. Theoretically, koff could also be
given by the intercept, but this value is less precise (see Supplementary material) The
kon value of yIF1 F17S, and therefore the koff value, are approximate (see text).
Peptide kon (M−1 s−1) KI (nM) koff (s−1)
yIF1 wT 3.2±0.3×105 b1 nd
[2.2±0.2×105] [b1] [nd]
yIF1 Δ1–13 3.9±0.2×105 b1 nd
[2.7±0.3×105] [b1] [nd]
yIF1 Δ1–14 3.3±0.3×105 2.9±0.5 9.6±2.5×10−4
[8.1±0.5×105] [b1] [nd]
yIF1 Δ1–15 6.5±0.9×105 4.4±0.7 2.9±0.9×10−3
[17.0±1.0×105] [1.8±0.2] [3.1±0.5×10−3]
yIF1 Δ1–16 9.1±1.8×105 20.3±2.1 1.9±0.6×10−2
[19.2±1.9×105] [8.1±1.9] [1.6±0.5×10−2]
PsaE-yIF1 2.6±0.1×105 10.9±1.5 2.8±0.5×10−3
[1.7±0.1×105] [6.4±0.8] [1.1±0.2×10−3]
yIF1 F17S 7.2±1.4×105 56.2±3.7 4.1±1.1×10−2
[2.4±0.5×105] [185±14] [4.4±1.3×10−2]
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concentration. This means that its Kd value is not negligible with
respect to the inhibitor concentrations used.
All the progression curves like those displayed in Fig. 3 could be
satisfactorily ﬁtted using a kinetic model in which the instantaneous
rate of ATP hydrolysis after inhibitor addition exponentially decayswith
time, from its initial value V(0) to a ﬁnal value V(I) [15,30] (see also
Eq. (1)). The time constant of the exponential decay (kapp) is the
apparent constant of inhibition. kappwaspreviously shown to be a linear
function of IF1 concentration, the proportionality coefﬁcient of which
gives the value of the rate constant of binding of IF1 to the enzyme
[14,30]. This linear relationship remains valid for all the truncated forms
of yIF1 (Fig. 4a). It is practically the same for yIF1 wT (closed circles),
yIF1 Δ1–13 (closed triangles), and yIF1 Δ1–14 (open triangles).
Therefore, removing the ﬁrst 13 or 14 residues does not signiﬁcantly
affect the kon value as given by the slope of the plot (3.2×105 M−1 s−1
for wT). On the other hand, removing the ﬁrst 15 or 16 residues
increases the kon value (about 9×105 M−1 s−1 for Δ1–16).
The extent of inhibition at the end of the inhibition kinetics was
given by the expression 1−V(I) /V(0). It was plotted as a function of
yIF1 derivatives concentration (Fig. 4b). At the lowest concentrationFig. 4. Rate constant of inhibition (kapp) (a) and maximal extent of inhibition (b) of isolated F
yIF1 wT; (- -▲- -) yIF1 Δ1–13; (—Δ—) yIF1 Δ1–14; (- -■- -) yIF1 Δ1–15; (—□—) yIF1 Δ1–16;
for yIF1 wT and three independent estimates for derivatives. Kinetic analysis performed as de
each data set with a linear regression (Materials and methods, Eq. (2)) or with a hyperboliused (20 nM), yIF1 wT inhibits ATP hydrolysis by practically 100%,
showing that the KI value is well below this concentration, as
previously observed [14]. The pattern is almost the same for yIF1
Δ1–13. Deletion of the ﬁrst 14, 15, and 16 residues progressively
decreases the afﬁnity of the inhibitory peptide for F1-ATPase, as
shown by the higher inhibitor concentrations required to obtain a
given level of inhibition. In all cases, F1-ATPase activity is almost fully
inhibited at saturating concentration of IF1 derivative.
The results are summarized in Table 2, in which the koff values have
been calculated from the productKI kon. koff cannot be estimated for yIF1
wT, but it can hardly exceed 10−4 s−1. Removal of Nter residues results
in a dramatic increase of koff (more than 100-fold), much more
important than kon increase (3-fold) when the ﬁrst 16th residues have
been removed. So the interaction of the Nter extremity of yIF1 is
important for the stabilization of the inhibited complex. Experiments
were also carried out using submitochondrial particles instead of
puriﬁed F1-ATPase (Table 2, data under brackets). The kon value of yIF1
wT is decreased by about 30%. This moderate decrease reﬂects a more
difﬁcult access of IF1 to its binding site in SMP, probably due to the1-ATPase as a function of yIF1 derivatives concentration. Conditions as in Fig. 3. (—●—)
(—○—) PsaE-yIF1. Each data point represents the average of six independent estimates
scribed under Materials andmethods, Eq. (1). Continuous lines were obtained by ﬁtting
c model of inhibition (Materials and methods, Eq. (3)).
Fig. 5. Partial reactivation of F1-ATPase activity after inhibition by yIF1 Δ1–16. Conditions as in Fig. 3 except for the time range. Panel a, time course of ATP hydrolysis showing the fast
inhibition following yIF1 Δ1–16 addition (vertical arrow) and the subsequent slow reactivation. Curve 1, 40 nM yIF1 Δ1–16; curve 2, 20 nM yIF1 Δ1–16. Panel b, instantaneous rate
of ATP hydrolysis versus time obtained from the ﬁrst derivative of the two spectrophotometer recordings displayed in panel a (same time scale). Rates expressed as percentage of the
rate before inhibitor addition. Panel c, remaining extent of inhibition at the end of the reactivation phase as a function of inhibitor concentration. The dashed curve recalls the extent
of inhibition obtained before the reactivation phase (see Fig. 4b).
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supramolecular organization of the complexes [31]. As in the case of
isolated F1-ATPase, deletion of Nter residues results in kon increase.
Remarkably, the kon values for yIF1 Δ1–14, Δ1–15, and Δ1–16 are even
higher than when using isolated F1-ATPase subcomplex. This suggests
that a non-steric factor is involved here (see Discussion).
F1-ATPase inhibited by yIF1 wT, Δ1–13, and Δ1–14 remained
permanently inactive. After yIF1 Δ1–15 or Δ1–16 addition, ATPase
activity ﬁrst reached a minimum corresponding to the levels of
inhibition plotted in Fig. 4b and then slowly increased. This reactivation
was most pronounced in the case of yIF1 Δ1–16. Fig. 5a shows the time
courseof F1-ATPase inhibition and reactivationover a long time range, at
two concentrations of yIF1 Δ1–16. The ﬁnal recovery of activity is only
partial (Fig. 5b). The remaining extent of ATPase inhibition at the end of
the reactivation decreases with yIF1 Δ1–16 concentration (Fig. 5c). As
compared to the transient inhibition reported in Fig. 4b (see also Fig. 5c,
dashed curve), the concentrations of yIF1 Δ1–16 required to obtain the
same inhibition is about 5 times higher.Since Phe17 is highly conserved
and was reported to play a key role [27], we also prepared the Δ1–17
truncated form. We found that this peptide might be able to inhibit the
F1-ATPase (results not shown). Unfortunately, it proved to bedifﬁcult to
purify, to be very unstable and sensitive to degradation. As a
consequence, no clear conclusion could be drawn about its inhibitory
properties.
3.3. Effect of F17S mutation on yIF1 inhibitory properties
The role of Phe17 was investigated using yIF1 F17S, which was
previously reported to bind to ATP synthase in a non-inhibitory way
[27]. Unexpectedly, we found that yIF1 F17S was able to fully inhibit
F1-ATPase but with a much lower afﬁnity than yIF1 wT and even than
the Nter-truncated derivatives: the KI value is about 60 nM with
isolated F1-ATPase and about 180 nM with SMP (Table 2; see also
Supplementary material). When this peptide was submitted to
trypsin proteolysis, its inhibitory power fully disappeared (data not
shown), which rules out any unspeciﬁc effect.
As for the truncated peptides, we also estimated the kon value of
yIF1 F17S. This was especially difﬁcult because the inhibition was
very fast and therefore its kinetics could be only resolved in a low
inhibitor concentration range, where the ﬁnal inhibition was not
complete. However, using F1-ATPase, kon could be grossly estimatedto 7×105 M−1 s−1, 2.5-fold the measured value for yIF1 wT, and
using SMP, estimated to 2×105 M−1 s−1, about the same value for
yIF1 wT (Table 2). So the F17S mutation acts on koff, not on kon.
3.4. Inhibition of ATP hydrolysis by PsaE-yIF1, a chimeric protein
In the bovine IF1-inhibited complex, IF1 deeply penetrates the
F1-ATPase and interactswith its central γ subunit by its Nter extremity
[26]. Attaching a bulky object to this extremity is therefore expected to
dramatically affect IF1 binding to the enzyme. To check this hypothesis
we produced a chimeric peptide in which the Nter extremity of wT
yIF1 was connected to PsaE, a globular-like protein, via a short spacer
(Figs. 1b and c). The 3D structure of PsaE is known, and this protein has
a sufﬁcient size to notably increase the steric hindrance at Nter
extremity of yIF1. Unexpectedly, the chimeric PsaE-yIF1 peptide
proved to fully inhibit ATPase activity with almost the same binding
rate constant for yIF1 wT (Fig. 4a, Table 2). It was veriﬁed that PsaE
protein alone had no effect on ATP hydrolysis (control not shown). The
kon values of PsaE-yIF1 are about 2.6×105 M−1 s−1 with isolated
F1-ATPase and 1.7×105 M−1 s−1 with SMP, that is 80% of the values
determined for yIF1 wT (Table 2). Thus, a considerable increase of
steric hindrance in Nter (Fig. 1b) has a very limited effect on the
recognition of IF1 binding site. The stability of the inhibited complex is
more sensitive to this modiﬁcation, as shown by the signiﬁcant
increase of KI and koff.
4. Discussion
4.1. Modiﬁcations of yIF1 inhibitory properties induced by progressive
truncation of its Nter extremity
The structure of bovine F1-ATPase in complex with IF1 shows that
the Nter extremity of the inhibitory peptide interacts with the central
part of the enzyme [26]. This suggests that its entry into the enzyme is
the ﬁrst step of binding. For the ﬁrst time, it was possible here to
observe the effect of modiﬁcations of the inhibitory peptide IF1 both
on its kinetic binding constant (kon) and on the dissociation constant
of the inhibited complex (estimated by KI), indirectly estimated from
the concentration dependency of the rate and extent of inhibition.
Using puriﬁed F1-ATPase, removing the ﬁrst 14 residues of yIF1 does
not change kon and somewhat increases KI (Table 2). This indicates
203T. Andrianaivomananjaona et al. / Biochimica et Biophysica Acta 1807 (2011) 197–204that these residues play no role in approach and recognition of yIF1
binding site. Deleting further the two next residues increases kon and
KI. This suggests that residues 15 and 16 somewhat hamper the early
step of binding. However, they are needed in the next step because
they contribute, as residue 14, to the stabilization of the inhibited
complex. Whereas kon is increased by a factor 3 by the removal of
residues 15 and 16, koff indeed is increased by a factor 20.
With yIF1 Δ1–15 and yIF1 Δ1–16, the inhibited complex slowly
reactivates (Fig. 5). Such a reactivation has been previously observed
in some Nter truncated mutants [24]. However, in those experiments,
the sample pre-incubated with the inhibitor at low pH was checked
for ATP hydrolysis after a dilution step, which favors IF1 release. Here,
reactivation is not due to dilution but probably due to a slow
conversion of the inhibited F1-ATPase into a form with a low afﬁnity
for IF1 and/or to some instability of the peptide. Whatever it may be,
this reactivation phenomenon may make KI determination ambigu-
ous. In the case of yIF1 Δ1–16, in which reactivation is most
pronounced, two different KI values are actually determined, one
before (KI=20 nM) and one after (KI=100 nM, Fig. 6c) reactivation.
Even the latter value remains well below all previously reported KI
values of inhibitory peptides similarly truncated in Nter [23].
In the crystallized bovine F1-ATPase in complex with IF1, the two
residues immediately preceding the conserved Phe21 (Phe17 in
yeast) do not interact with the central γ subunit. This suggests that
stabilization of the yeast inhibited complex by residues 15–16 does
not involve γ subunit, but the fact that these residues are not
conserved and that the structure of the yeast inhibited complex is not
yet available forbids deﬁnite conclusion.
As expected from the slightly diminished accessibility of IF1
binding site in SMP, yIF1 wT and yIF1 Δ1–13 bind a little bit more
slowly to the membrane-bound ATP synthase than to the isolated F1-
ATPase subcomplex. The different yIF1 modiﬁcations have qualita-
tively the same consequences with the membrane-bound enzyme as
with the solubilized one, except that kon increase starts from the
removal of the 14th (instead of the 13th) residue and is more
pronounced after removing residues 15 and 16. Contrary to yIF1 wT
and yIF1 Δ1–13, yIF1 Δ1–14, yIF1 Δ1–15, and yIF1 Δ1–16 bind more
rapidly to membrane-bound ATP synthase than to isolated F1-ATPase.
A possible explanation is the fact that, at pH 6.5, yIF1 and derivatives
are positively charged and are therefore expected to somewhat
accumulate near the membrane that is negatively charged [32]. In the
case of yIF1 wT and yIF1 Δ1–13, the net charge (theoretically 2.3
positive charges permolecule) is not high enough to balance the steric
effects of the membranous environment and kon is globally decreased
in SMP. With the signiﬁcant charge increase of yIF1 Δ1–14 (3.3
charges), Δ1–15 (4.3 charges), and Δ1–16 (4.3 charges) due to loss of
acidic residues, the electrostatic effect can outmatch the steric effect.
Interestingly, the koff value, which is not expected to depend on the
local yIF1 concentration, is the same with SMP and isolated F1-ATPase
in the case of yIF1 Δ1–15 and yIF1 Δ1–16.
4.2. Re-examined importance of the conserved phenylalanine 17
The amino acid immediately following residues 15–16 (Phe17) is a
kind of milestone in IF1 sequence. It is the starting point of the
well-conserved inhibitory sequence. In crystallized inhibited bovine
F1-ATPase, its counterpart Phe22marks theborder between theNter part
of IF1 wrapped around the γ subunit and its mid-part locked between
αDP and βDP. Mutation of Phe17 into serine was previously reported to
make thepeptidenon-inhibitory at concentrationsup to5 μM.Moreover,
yIF1 F17S was proposed to competitively prevent inhibition by yIF1 wT
[27]. In the present work, yIF1 F17S proved to inhibit isolated F1-ATPase
as well as membrane-bound F0F1-ATPase with a KI value of 60 and
180 nM, respectively (Table 2). This discrepancy can be at least partially
explained by the fact that previous investigators measured ATPase
activity of theyIF1-pretreated sample after diluting it 50-fold in ahighpHmedium. In particular, the apparently silent bindingof yIF1 F17S couldbe
due to a true competition during the incubation stage, followed by a
release of yIF1 F17S without yIF1 wT binding after the dilution. To
conclude, Phe17 is not mandatory for the inhibitory effect and silent
binding of yIF1 F17S is unlikely. However, Phe17 contributes to the
stability of the inhibited complex. This is not unexpected since in the
crystallized bovine inhibited complex, Phe22 is mainly surrounded by
the conserved hydrophobic residues βDPA389, βTPI390, βTPL391, and
γI16.
4.3. Reappraisal of previous results
The effect of signiﬁcant Nter deletions of mammal [22–25] and
yeast [23] IF1 has already been investigated. Deletions not including
the residue immediately preceding the milestone phenylalanine
always preserved the inhibitory properties. Additional removal of
residue 16 (yeast) or residue 21 (bovine) gave conﬂicting results. In
some reports [23,25], such truncated IF1 peptides of B. taurus, Candida
utilis, S. cerevisiae, and Rattus norvegicus were found to still inhibit
ATPase activity, sometimes with a very low afﬁnity for the enzyme
[25]. In another report [24], the same deletion in B. taurus IF1 made
the peptide apparently ineffective. The different procedures used
probably account for these variations. In experiments showing an
inhibitory effect, inhibition and ATPase assay were conducted in a
single step [23], whereas in other experiments, the activity was
assayed after diluting the inhibited sample [24]. As already discussed,
the latter protocol probably led to the release of the truncated
peptides and then to a general overestimation of KI or even to an
apparent loss of inhibitory power. Only direct assays as in reference 23
or as in the present work provide reliable values of binding
parameters.
The KI value of yIF1Δ1–16 determined here (Fig. 4, Table 2) remains
much lower than the KI value of the yIF1 fragment 17–41 previously
studied at the same pH [23]: 20 nM versus 4 μM. The following two
explanations could be proposed for this high difference of afﬁnities: 1) a
non-negligible role of the residues 42–63 of yIF1 in its binding
properties; and 2) a better afﬁnity of the peptide for yeast F1-ATPase,
used here, than for the bovine F1-ATPase, used in reference 23.
Whatever it may be, the present work clearly demonstrates that yIF1
lacking all of the residues preceding Phe17 (Phe22 in bovine) is still
inhibitory and binds to puriﬁed F1-ATPase and membrane-bound
F0F1-ATPase with a higher afﬁnity than generally reported. By
comparison, the dissociation constant of the inhibitory ε subunit of
isolated photosynthetic F1-ATPases is about 4 nM for thiol-reduced
chloroplast ATPase [33,34] and 1 nM for cyanobacterial ATPase [35]. It is
remarkable that evenafter eliminationof itsﬁrst 14 residues, the afﬁnity
of yIF1 for isolated mitochondrial F1 subcomplex is comparable to the
afﬁnity of ε, a permanent component of the rotor, for isolated
photosynthetic F1 subcomplex.
Here, we conﬁrmed that deletion of all the residues preceding
Phe17 preserves the inhibitory property of IF1 but signiﬁcantly
decreases its afﬁnity for its target. This indicates that wrapping the
Nter extremity of IF1 around ATP synthase γ subunit does not directly
participate in the inhibition process but stabilizes the inhibited
complex. The KI of PsaE-IF1 is intermediate between the KI of yIF1
Δ1–15 and Δ1–16. It is not surprising that attaching a globular protein
in Nter and deleting the Nter extremity result in similar loss of afﬁnity
because both modiﬁcations disrupt the interaction with γ.
4.4. Conclusions
Until now the role of the Nter part of IF1 had only been
investigated by using truncated mutants in experiments in which
kinetic aspects were not considered. Here, time-resolved experiments
using progressively truncated peptides allowed to precise the role of
the different amino acids of the Nter part of yIF1 in the successive
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also brought complementary information. The fact that PsaE-yIF1
chimeric protein binds to isolated F1-ATPase almost at the same rate
as yIF1 wT was rather unexpected. In SMP, this was still more
surprising, although the steric hindrance due to PsaE may be partially
compensated by a high positive charge (4.9 charges per PsaE-yIF1
molecule) favoring the peptide attraction by the membrane. The
cavities between ATP synthase subunits are so narrow that, once
attached to PsaE, the Nter extremity of IF1 could hardly present to the
center of the enzymatic complex. Therefore, among the possible
conformations of PsaE-yIF1, the only ones expected to allow binding
are those with the Nter extremity folded backwards. Since yIF1 wT
and PsaE-yIF1 have comparable kon values, the proportion of favorable
conﬁgurations is almost the same for both peptides. It is then probable
that the Nter extremity (up to the 14th residue, see Table 2) folds
backwards in the natural conﬁguration for wT yIF1 binding. This
suggests an outline of the different steps of IF1 binding to ATP
synthase. In the above-described conformation, IF1 binds by its mid-
part to a catalytic interface that is nucleotide-free [26] or that has just
bound ATP [16,36]. In a second step, the Nter extremity winds around
the γ subunit. This stabilizes the inhibited complex but only through
the three residues preceding the conserved Phe17. At present time,
such a step-by-step dissection of this binding mechanism can be
achieved only using a kinetic approach.
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